Literature DB >> 31664224

JAK inhibitors alter NK cell functions and may impair immunosurveillance against lymphomagenesis.

Gaetane Nocturne1,2, Juliette Pascaud3, Bineta Ly3, Farhad Tahmasebi3, Xavier Mariette3,4.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31664224      PMCID： PMC7193549          DOI： 10.1038/s41423-019-0320-3

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  5 in total

Review 1.  Histone Modifications and Their Targeting in Lymphoid Malignancies.

Authors:  Miranda Fernández-Serrano; René Winkler; Juliana C Santos; Marguerite-Marie Le Pannérer; Marcus Buschbeck; Gaël Roué
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

2.  Tofacitinib Suppresses Natural Killer Cells In Vitro and In Vivo: Implications for Amyotrophic Lateral Sclerosis.

Authors:  Claudia Figueroa-Romero; Alina Monteagudo; Benjamin J Murdock; Joshua P Famie; Ian F Webber-Davis; Caroline E Piecuch; Samuel J Teener; Crystal Pacut; Stephen A Goutman; Eva L Feldman
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 8.786

Review 3.  Oral surveillance and JAK inhibitor safety: the theory of relativity.

Authors:  Kevin L Winthrop; Stanley B Cohen
Journal:  Nat Rev Rheumatol       Date:  2022-03-22       Impact factor: 32.286

Review 4.  The Role of the Oral Immune System in Oropharyngeal Candidiasis-Facilitated Invasion and Dissemination of Staphylococcus aureus.

Authors:  Raymond Pasman; Bastiaan P Krom; Sebastian A J Zaat; Stanley Brul
Journal:  Front Oral Health       Date:  2022-04-07

Review 5.  Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors-A Strategy for Hematological Malignancies?

Authors:  Klara Klein; Dagmar Stoiber; Veronika Sexl; Agnieszka Witalisz-Siepracka
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.